Clinical trial
Phase I Study to Assess the Safety of APD-791 When Co-administered With Aspirin
NCT02034292 is registered in ClinicalTrials.gov with IlDong Pharmaceutical Co Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study to Assess the Safety of APD-791 When Co-administered With Aspirin
- Lead sponsor
- IlDong Pharmaceutical Co Ltd
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- February 28, 2014
- Completion date
- March 31, 2014
- Enrollment
- 16 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.